Literature DB >> 8626782

The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats.

J M Shipley1, G A Doyle, C J Fliszar, Q Z Ye, L L Johnson, S D Shapiro, H G Welgus, R M Senior.   

Abstract

Several matrix metalloproteinases, including the 92-kDa and 72-kDa gelatinases, macrophage metalloelastase (MME), and matrilysin degrade insoluble elastin. Because elastolytically active MME and matrilysin consist only of a catalytic domain (CD), we speculated that the homologous CDs of the 92-kDa and 72-kDa gelatinases would confer their elastolytic activities. In contrast to the MME CD, the 92 and 72 CDs expressed in Escherichia coli (lacking the internal fibronectin type II-like repeats) had no elastase activity, although both were gelatinolytic and cleaved a thiopeptolide substrate at rates comparable to the full-length gelatinases. To test the role of the fibronectin type II-like repeats in elastolytic activity, we expressed the 92-kDa gelatinase CD with its fibronectin type II-like repeats (92 CD/FN) in yeast. 92 CD/FN degraded insoluble elastin with activity comparable to full-length 92-kDa gelatinase. 92 and 72 CDs lacking the fibronectin type II-like repeats did not bind elastin, whereas the parent enzymes and 92 CD/FN did bind elastin. Furthermore, recombinant 92-kDa fibronectin type II-like repeats inhibited binding of the 92-kDa gelatinase to elastin. We conclude that the 92- and 72-kDa gelatinases require the fibronectin type II-like repeats for elastase activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626782     DOI: 10.1074/jbc.271.8.4335

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.

Authors:  Gillian Murphy
Journal:  Int J Exp Pathol       Date:  2010-08       Impact factor: 1.925

3.  Apparent tradeoff of higher activity in MMP-12 for enhanced stability and flexibility in MMP-3.

Authors:  Xiangyang Liang; A Arunima; Yingchu Zhao; Rajagopalan Bhaskaran; Anuradha Shende; Todd S Byrne; Jeremy Fleeks; Mark O Palmier; Steven R Van Doren
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

4.  Neprilysin is identical to skin fibroblast elastase: its role in skin aging and UV responses.

Authors:  Naoko Morisaki; Shigeru Moriwaki; Yoriko Sugiyama-Nakagiri; Keiichi Haketa; Yoshinori Takema; Genji Imokawa
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

Review 5.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

6.  Matrix metalloproteinase 9 gene polymorphisms are associated with a multiple family history of gastric cancer.

Authors:  Rieko Okada; Mariko Naito; Yuta Hattori; Toshio Seiki; Kenji Wakai; Hinako Nanri; Miki Watanabe; Sadao Suzuki; Tara Sefanya Kairupan; Naoyuki Takashima; Haruo Mikami; Keizo Ohnaka; Yoshiyuki Watanabe; Sakurako Katsuura-Kamano; Michiaki Kubo; Nobuyuki Hamajima; Hideo Tanaka
Journal:  Gastric Cancer       Date:  2016-04-06       Impact factor: 7.370

7.  Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Nusayba A Bagegni; Xiangyang Liang; Steven R Van Doren
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

Review 8.  Neutrophils in asthma.

Authors:  Ana L Macdowell; Stephen P Peters
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

9.  Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.

Authors:  Rebecca Brooks; Nora Kizer; Loan Nguyen; Atthapon Jaishuen; Karolyn Wanat; Elizabeth Nugent; Perry Grigsby; Jenifer E Allsworth; Janet S Rader
Journal:  Gynecol Oncol       Date:  2009-11-10       Impact factor: 5.482

10.  Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling.

Authors:  Baohong Jiang; Jing Chen; Lingling Xu; Zhenting Gao; Yanping Deng; Yanhui Wang; Feng Xu; Xu Shen; De-An Guo
Journal:  BMC Pharmacol       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.